INVIVOID
LIVE

Serial Number

79420740

Owner

TOPPAN Holdings Inc.

Attorney

Sean K. Owens

Filing Date

Feb 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

INVIVOID Trademark

Serial Number: 79420740

INVIVOID is a trademark filed by TOPPAN Holdings Inc. on February 13, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

TOPPAN Holdings Inc. (2 trademarks)

5-1, Taito 1-chome,

Entity Type: 03

Trademark Details

Filing Date

February 13, 2025

Registration Date

Not Registered

Goods & Services

Laboratory apparatus and instruments, namely, incubators for bacteria culture; photographic machines and apparatus, namely, cameras; optical machines and apparatus, namely, scanners and microscopes; measuring or testing machines and instruments, namely, electronic apparatus for electrophysiological measurement and testing of cells; personal digital assistants; computer programs, namely, software as a medical device (SaMD), downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; computer software, recorded, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; computer software applications, downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; recorded computer operating programs; computer programs, downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; computer software platforms, recorded and downloadable, for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; downloadable graphics for mobile phones; downloadable emoticons for mobile phones; downloadable image files for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; recorded video discs and video tapes for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; electronic publications, namely, downloadable newsletters in the nature of personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; telepresence robots.

Pharmaceutical preparations for personalized cancer medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food, and other preparations for destroying vermin, fungicides, herbicides; reagent paper for medical purposes; biological tissue cultures for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological culture mediums for medical purposes; diagnostic media for bacteriological cultures for medical purposes; stem cells for medical purposes; biological preparations for the treatment of cancer for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; empty capsules for pharmaceuticals; semen for artificial insemination; cell culture media for medical purposes for use in toxicity tests, drug discovery research, cultured foods, regenerative medicine and personalized medicine in the fields of cancer and 3D cell culture.

Designing of machines, apparatus, instruments or systems composed of such machines, apparatus and instruments; computer programming; information technology (IT) support services, namely, troubleshooting of computer software and hardware problems; artificial intelligence technology consultancy; computer system design; development of computer platforms; recovery of computer data; data security consultancy; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; culturing of cells for others for scientific research purposes; conducting technical project scientific feasibility studies; rental of measuring apparatus; rental of computers; providing temporary use of online non-downloadable computer programs on data networks for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; rental of web servers; rental of computer software for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; platform as a service (PaaS) services featuring software for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; software as a service (SaaS) services featuring software for use in personalized medicine, medical diagnostics, drug discovery and development, clinical laboratory testing, and cultured food in the fields of cancer and 3D cell culture; providing virtual computer systems through cloud computing; server hosting; electronic data storage; rental of laboratory apparatus and instruments; design and testing of new products relating to cell culture for use in toxicity tests, drug discovery research, cultured foods, regenerative medicine and personalized medicine in the fields of cancer and 3D cell culture; research services for the development of new products relating to cell culture for use in toxicity tests, drug discovery research, cultured foods, regenerative medicine and personalized medicine in the fields of cancer and 3D cell culture.

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 24, 2026 GNFN
FINAL REFUSAL E-MAILED
Feb 24, 2026 GNFR
FINAL REFUSAL WRITTEN
Feb 24, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2026 TROA
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 16, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 15, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 4, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 3, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 3, 2025 REPR